From: APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
Cancer type | APOBEC3(s) overexpressed* | Expression type* | Correlated tumor mutation burden(s)** | References |
---|---|---|---|---|
Multiple | 3A, 3B*, 3F, and 3G | mRNA* | APOBEC3-induced | [27] |
Adrenal | 3B | mRNA* and protein | Overall | [44] |
B-cell lymphoma | 3B and 3C | mRNA | N/A | [45] |
Bile duct | 3A* and 3B (No healthy tissue control) | mRNA | APOBEC3-induced | [43] |
Bladder | 3B* | Protein | N/A | [35] |
 | 3B | mRNA | Not detected | [27] |
 | 3B | mRNA | N/A | [34] |
 | 3A* and 3B* | mRNA* | APOBEC3-induced | |
 | 3B1 | mRNA and protein | N/A | [1] |
Breast | 3A*, 3B*, and 3H | mRNA* | APOBEC3-induced | [27] |
 | 3B | mRNA | N/A | [34] |
 | 3B* | mRNA* | APOBEC3-induced, overall | [22] |
 | 3A* and 3B | mRNA* | APOBEC-induced | [47] |
 | 3A*, 3B*, and C3-H | mRNA* | APOBEC3-induced, overall | [48] |
Cervical | 3B | mRNA | N/A | [34] |
Esophageal | 3B* | mRNA and protein* | APOBEC3-induced in PIK3CA | [39] |
Gastric | 3B* | Protein* | Overall | [37] |
 | 3B | mRNA and protein | N/A | [38] |
Glioma | 3B, 3C, 3D, 3F, 3G, 3H | mRNA* | Overall | [51] |
Head and neck | 3B | mRNA | N/A | [34] |
Kidney | 3B | mRNA | N/A | [34] |
Leukemia | 3A | mRNA | N/A | [52] |
Lung | 3B* | mRNA* | APOBEC3-induced | [27] |
 | 3B* | mRNA* | APOBEC3-induced, overall | [53] |
 | 3B* | mRNA* | APOBEC3-induced | [54] |
 | 3B | mRNA | N/A | [34] |
 | 3B | mRNA | N/A | [36] |
Nasopharyngeal | 3B | Protein | N/A | [55] |
Ovarian | 3B | Protein | N/A | [42] |
 | 3B | mRNA* and protein | Overall | [41] |
 | 3B* | mRNA* | Overall | [56] |
Pancreatic | 3G | mRNA and protein | N/A | [49] |
Penile | 3A (In subset) | Protein | N/A | [57] |
Prostate | 3B | mRNA | N/A | [34] |
Skin | 3B | mRNA | N/A | [34] |
Uterus | 3B | mRNA | N/A | [34] |